Solesence Earnings Call: Key Takeaways
Solesence achieved record Q3 revenue and net income driven by lean management initiatives, though management lowered full-year EBITDA margin guidance due to first-half weakness.
- Call
- Nov 12, 2026, 5:00 PM ET
ALFA USA Filings
Every alert, straight from SEC EDGAR
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Solesence, Inc. filings on SEC EDGAR ↗
Filing type
Alerts
Time
5 alerts
Solesence achieved record Q3 revenue and net income driven by lean management initiatives, though management lowered full-year EBITDA margin guidance due to first-half weakness.
Solésence, Inc. reported a net income of $3.67 million for the third quarter of 2026, a significant recovery from a $1.02 million net loss in the prior year period, driven by a 38% increase in total revenue. For the nine months ended September 30, 2026, the company generated $8.4 million in cash from operating activities, compared to a $10.4 million cash burn in the same period of 2025.
Solésence reported record third quarter 2026 financial results, with revenue increasing 38% year-over-year to $20.2 million. The company achieved its highest-ever quarterly net income of $3.7 million, driven by operational excellence and strong demand from brand partners.
“We’re very pleased that Solésence delivered solid top line growth as well as steady operational and strategic progress in the third quarter, driven by key milestones across our Transform and Transcend framework. Most notably, we reached a major turning point by completing the primary investment and implementation phase of our first pillar, operational excellence. This elevated capacity and efficiency position us to meet robust demand from our brand partners today while seamlessly scaling for tomorrow. Paired with our continued innovation in novel formulations and expanding global presence, Solésence is uniquely positioned to deliver long-term, profitable growth and lead the market in meeting evolving consumer needs.”
Kevin Cureton, President and CEO
“By pairing record revenue and net income with strong margin expansion, we have positioned Solésence for sustained growth. The operational and financial improvements achieved throughout 2026 provide a strong foundation as we look ahead to 2027.”
Laura Riffner, Chief Financial Officer
Solésence, Inc. entered into amendments for three separate loan agreements with affiliates of its controlling shareholder, Bradford T. Whitmore. The amendments extend the maturity dates for the Term Loan, A/R Loan, and Revolving Loan from April 30, 2027, to May 31, 2028.
Solésence, Inc. received a deficiency notice from Nasdaq on September 29, 2026, because its common stock closing bid price fell below the $1.00 minimum requirement for 30 consecutive trading days. The company has 180 calendar days, until March 29, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive trading days. If compliance is not met by then, the company may be eligible for an additional 180-day grace period if it meets other listing standards.